Research group focused on circulating biomarkers and clinical utility-oriented translational research
Italy
Joined January 2019
- Tweets99
- Following54
- Followers291
- Likes72
The Liquid Biopsy Research Group retweeted
Can #fragmentomics become a new monitoring #biomarker in metastatic breast cancer? 🔬
👉 Here we explore a mutation-agnostic, cost-effective approach tested in the MAGNETIC.1 trial—a longitudinal study of first-line HR+/HER2- MBC.
doi.org/10.1016/j.tranon.202…
The Liquid Biopsy Research Group retweeted
🏁 Our program on cellular residual disease in triple negative breast cancer is about to launch!
Detecting circulating tumor cells in early #TNBC will provide deeper insights into the metastatic process and #immunotherapy response
#BreastCancer #LiquidBiopsy #CTC @CroAviano
The Liquid Biopsy Research Group retweeted
CDK4/6 inhibitors: mechanisms of resistance and where to find them.
An outside of the box review
Main takeaways:
🛑RB1 loss in #ctDNA predicts poorer PFS
⚠️CCNE1 gain impacts PALOMA-3 outcomes
🧩Role of ESR1 still unclear
Read more👇
sciencedirect.com/science/ar…
#bcsm #BreastCancer
The Liquid Biopsy Research Group retweeted
🔬 #ASCO2024 Insight: Dr @LGerratana discusses the genomic profiling of PR-negative and ER-low breast cancer subtypes. ER-low tumours show a mutational profile similar to triple-negative breast cancer, suggesting benefits from immunotherapy.
The Liquid Biopsy Research Group retweeted
#ctDNA is gaining importance in #breastcancer. But what are its real clinical prospects? Excited to share our perspective: 'Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?' 👉 doi.org/10.1080/14737140.202…
The Liquid Biopsy Research Group retweeted
Is ER low metastatic #BreastCancer a TNBC-like disease subtype?
Check our circulating tumor DNA analysis
📍Poster Bd # 17 - Hall A, Metastatic Breast Cancer session
⏱️ 9:00 AM - 12:00 PM #ASCO24 #ctDNA #bcsm #liquidbiopsy
The Liquid Biopsy Research Group retweeted
Say hello to OLGA, @CroAviano persOnaLized oncoloGy cAre flow platform
It’s time to move from the paradigm of #PrecisionMedicine in #Oncology to a broader concept of #Personalized #Care, where treatments and monitoring strategies are holistically tailored around every person.
The Liquid Biopsy Research Group retweeted
Great opportunity to get in touch with the International Society of Liquid Biopsy (ISLB @isliquidbiopsy) at booth 10027! #ASCO24 #LiquidBiopsy
🚀 Excited to be at #ASCO2024! Visit us at booth 10027 to learn more about the International Society of Liquid Biopsy (ISLB) and our latest advancements. See you there! #LiquidBiopsy #CancerResearch #ISLB #ASCO2024
The Liquid Biopsy Research Group retweeted
Join Francois-Clement Bidard at the 20th Anniversary of Circulating Tumor Cells in Granada, Spain from May 24-25, 2024.
Francois-Clement Bidard, MD PhD, is a Professor of Medical Oncology at Institut Curie & Versailles University, and also the vice-chair or the French breast cancer research group UCBG/Unicancer.
For more information, please contact [email protected].
#CTC20thAnniversary #SpeakerSpotlight
@MJOSESERRANO19
@MCristofanill
The Liquid Biopsy Research Group retweeted
Be part of the 20th Anniversary of Circulating Tumor Cells, organized by ISLB!
📅 Save the date for May 24 - 25, 2024, and join us as we unveil the impact of Circulating Tumor Cells, exploring two decades of discovery and clinical advancements in solid tumors.
Chairs:
@MCristofanill
@MJOSESERRANO19
Hosted at Centro Pfizer-University of Granada-Junta De Andalucia De Genomica E Investigación Oncologica, Granada, Spain.
Don't miss this opportunity to be part of the future of cancer research and treatment! More information please write to [email protected]
The Liquid Biopsy Research Group retweeted
What is the role of synonymous mutations (SYN) and variants of unknown significance (VUS) detected though #ctDNA next generation sequencing?
Some interesting insights presented by @Elisabetta_mol at the #SABCS23 poster session
#LiquidBiopsy #MBC – at San Antonio, TX
The Liquid Biopsy Research Group retweeted
Check our companion posters on genetic and epigenetic #ctDNA profiling according to PR status in metastatic #breastcancer.
🔴during 1st line ET
🔼 ESR1 promoter methylation in PRpos
🔴after 1st line:
🔼ESR1 mut in PRpos #MBC
🔼GATA3 mut in PRneg #MBC
#SABCS23 #liquidbiopsy – at San Antonio, TX
The Liquid Biopsy Research Group retweeted
Moving from prognostication to pattern of progression at the #ESMO23 poster session with @lindacucciniel1 . Hazard distribution has different patterns across clinical and #LiquidBiopsy subgroups: can we #personalize disease monitoring in metastatic #BreastCancer?
The Liquid Biopsy Research Group retweeted
A recent prospective study delved into baseline pharmacological profiling in patients treated for metastatic #BreastCancer using #palbociclib
🧵3/5
linkinghub.elsevier.com/retr…
#MBC
The Liquid Biopsy Research Group retweeted
Body mass index impacts #AdverseEvents and drug plasma concentration in patients with #BreastCancer: should dose intensity be included in the #palbociclib equation? a letter ✉️ (👇below) and a thread🧵
@rossanaroncato @puglisi_fabio
link.springer.com/article/10…
The Liquid Biopsy Research Group retweeted
🌐 1 multi-institutional consortium, 703 patients
🧬 single codon and Pathway classification
📊 ESR1 537 associated with alterations in the ER, RAF and MYC pathways, ESR1 538 to cell cycle pathway
🩻 ESR1 538 linked to liver mets; ESR1 537 and PIK3CA 1047 & 542 to bone mets
The Liquid Biopsy Research Group retweeted
Moving from the simplistic definition of #ESR1 and #PIK3CA mutated metastatic #BreastCancer to a more granular resolution of single codon variants thanks to #ctDNA and #LiquidBiopsy for a more precise biological and clinical profiling of #MBC
breast-cancer-research.biome…
The Liquid Biopsy Research Group retweeted
@genyo_pts @jjdmochon @mromerogomez @SEAP_IAP @flo_encarna @tweet_Javi @Dolmos77 @evilarsan @evi_lianidou @JAguirreGhiso @LiquidBiopsyLab @LiquidBioTeam @LiquidBiopsyNow @biopsy_liquid
Innovate, Connect, Inspire: Submit Your Abstract to #ISLB23 by 7 July 2023!
Join the leading minds in #LiquidBiopsy research and contribute to the future of diagnostics and therapeutics. Visit 2023.islb.info/pw0n for more details.
@Oncoalert @4oncommunity @ChristianRolfo @UmbertoMalapel1 @ElJanLe @MJOSESERRANO19 @drgandara
The Liquid Biopsy Research Group retweeted
First results of the NATALEE trial, on ribociclib as adjuvant option in early #BreastCancer. Primary endpoint was met: IDFS (HR 0.75, p 0.0014), consistent in all subgroups #ASCO23 #bcsm
The Liquid Biopsy Research Group retweeted
Tumor informed #ctDNA monitoring in the PENELOPE-B. Longitudinal characterization is promising to determine treatment response, although relapses are also observed in the ctDNA negative group. Sensitivity is crucial to support future MRD-driven treatment strategies #ASCO23 #bcsm
